Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Phthalates Linked to Reduced Fertility in IVF

By HospiMedica International staff writers
Posted on 23 Jul 2013
Urinary metabolite levels of di-2-ethylhexyl-P (DEHP) phthalates are associated with a significantly higher risk of in vitro fertilization (IVF) failure.

Researchers at Massachusetts General Hospital (MGH; Boston, USA) conducted a prospective cohort study involving 231 women (aged 18-45) who had had a total of 325 fresh treatment cycles at the MGH Fertility Center between 2004 and 2012. More...
Urine samples were obtained at the start of treatment and either at the early/mid-follicular phase or at oocyte retrieval. The researchers measured urinary metabolites of several phthalates, including mono(2-ethylhexyl)-P (MEHP), monobutyl-P (MBP), and the sum of di-2-ethylhexyl-P phthalates (sum-DEHP).They also assessed various markers of response to IVF, including serum peak estradiol, implantation failure, and the number of retrieved, mature, and fertilized oocytes.

The results showed that urinary phthalates were present in over 95% of the samples, with significant increased risks of IVF failure across increasing quartiles of sum-DEHP levels; a similar pattern was detected for the metabolite MBP, but the relationship was not significant. The researchers also found a decline in the number of retrieved oocytes with increasing MEHP quartiles, and a similar trend with increasing sum-DEHP quartiles, although it was not significant. There was also a decrease in the number of mature oocytes with increasing MEHP quartiles and sum-DEHP metabolites. The study was presented at the European Society of Human Reproduction and Embryology meeting, held during July 2013 in London (United Kingdom).

“Phthalates, chemicals found in plastics, fragrances, and cosmetics, may affect the chances of successful in vitro fertilization,” concluded lead author Irene Souter, MD, and colleagues. “However, there were no associations between urinary phthalate metabolites and peak estradiol, rates of fertilization, or embryonic cleavage. The study was limited because it precluded assessment of long-term exposure to phthalates, and because the results may not be generalizable to women who are conceiving naturally.”

Phthalates are used primarily to soften polyvinyl chloride (PVC) in a large variety of products, include adhesives and glues, electronics, agricultural adjuvants, building materials, personal-care products, medical devices, detergents and surfactants, packaging, children's toys, pharmaceuticals, food products, textiles and more. People are commonly exposed to phthalates since they are easily released into the environment, and as a result, phthalates are being phased out of many products in the United States, Canada, and European Union due to health concerns.

Related Links:

Massachusetts General Hospital



Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Tourniquet System
heidi– mein Tourniquet
Medical Examination & Procedure Light
Vega 80
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Clinical LLM Performance Improves by >300% When Provided with High-Quality Real-World Evidence in New Precision Medicine Benchmark (Photo courtesy of Atropos Health)

New Benchmark Highlights Evidence Gaps in AI Responses to Clinical Questions

Many clinical decisions still rely on limited evidence, while most artificial intelligence benchmarks overlook the patient context that shapes real-world care. General large language models can also struggle... Read more

Critical Care

view channel
Image Credit: Adobe Stock

New ECG Foundation Model Enables Broad Cardiac Diagnosis and Risk Prediction

Electrocardiograms are central to cardiovascular decision-making, but conventional artificial intelligence models are often trained for narrow tasks, such as detecting a single arrhythmia.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.